XML 80 R63.htm IDEA: XBRL DOCUMENT v3.10.0.1
DIVESTITURES - Narrative (Details)
divestiture in Millions
3 Months Ended 7 Months Ended 12 Months Ended 25 Months Ended
Dec. 20, 2017
USD ($)
Nov. 09, 2017
USD ($)
Sep. 29, 2017
USD ($)
Jun. 28, 2017
USD ($)
Mar. 03, 2017
USD ($)
Dec. 07, 2016
USD ($)
Sep. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
Nov. 08, 2017
USD ($)
Dec. 31, 2018
USD ($)
divestiture
country
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2018
USD ($)
country
Asset acquisitions and disposition                          
Number of material divestitures | divestiture                   0      
Number of countries in which entity operates (more than) | country                   90     90
Held For Sale                          
Asset acquisitions and disposition                          
Impairment write-down                   $ 5,000,000 $ 114,000,000 $ 88,000,000  
CeraVe, AcneFree, AMBI Skincare Brand                          
Asset acquisitions and disposition                          
Gain (loss) on sale of business                   0 309,000,000 0  
CeraVe, AcneFree, AMBI Skincare Brand | Held For Sale                          
Asset acquisitions and disposition                          
Net cash proceeds         $ 1,300,000,000                
Gain (loss) on sale of business                     309,000,000    
Dendreon                          
Asset acquisitions and disposition                          
Gain (loss) on sale of business                   0 97,000,000 0  
Dendreon | Held For Sale                          
Asset acquisitions and disposition                          
Net cash proceeds       $ 845,000,000                  
Gain (loss) on sale of business                     97,000,000    
iNova                          
Asset acquisitions and disposition                          
Gain (loss) on sale of business                   $ 0 309,000,000 0  
iNova | Held For Sale                          
Asset acquisitions and disposition                          
Net cash proceeds     $ 938,000,000                    
Gain (loss) on sale of business                     309,000,000    
Number of countries in which entity operates (more than) | country                   15     15
Obagi Medical Products, Inc. | Held For Sale                          
Asset acquisitions and disposition                          
Impairment of finite-lived intangible assets                 $ 103,000,000        
Obagi Medical Products, Inc. | Disposal Group, Disposed of by Sale, Not Discontinued Operations                          
Asset acquisitions and disposition                          
Net cash proceeds   $ 190,000,000                      
Gain (loss) on sale of business                     (13,000,000)    
Sprout                          
Asset acquisitions and disposition                          
Gain (loss) on sale of business                   $ 0 (98,000,000) 0  
Loan term 5 years                        
Related party loan $ 25,000,000                        
Sprout | Minimum                          
Asset acquisitions and disposition                          
Purchase obligation (no less than) $ 200,000,000                        
Sprout | Held For Sale                          
Asset acquisitions and disposition                          
Impairment write-down                     351,000,000    
Sprout | Disposal Group, Disposed of by Sale, Not Discontinued Operations                          
Asset acquisitions and disposition                          
Gain (loss) on sale of business                     $ (98,000,000)    
Royalty percentage 6.00%                        
Ruconest Divestiture                          
Asset acquisitions and disposition                          
Impairment of finite-lived intangible assets                       $ 221,000,000  
Ruconest Divestiture | Disposal Group, Disposed of by Sale, Not Discontinued Operations                          
Asset acquisitions and disposition                          
Impairment of finite-lived intangible assets               $ 199,000,000          
Consideration received from divestiture           $ 60,000,000              
Additional loss           22,000,000              
Ruconest Divestiture | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Maximum                          
Asset acquisitions and disposition                          
Consideration received from divestiture           125,000,000              
Ruconest Divestiture Sales Based Milestone Component | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Maximum                          
Asset acquisitions and disposition                          
Consideration received from divestiture           $ 65,000,000              
Sales-based milestones achieved                         $ 20,000,000
Paragon Holdings I, Inc. Divestiture | Disposal Group, Disposed of by Sale, Not Discontinued Operations                          
Asset acquisitions and disposition                          
Loss on disposal             $ 19,000,000